Sign In
Buy FREQ
$0.300
+0 (+0%)
At Close: Feb 02, 2024
Frequency Therapeutics to Participate at Upcoming March Investor Conferences
07:30am, Monday, 27'th Feb 2023
LEXINGTON, Mass.--(BUSINESS WIRE)--Frequency Therapeutics, Inc. (Nasdaq: FREQ), a regenerative medicine company focused on developing therapeutics to activate a person's innate potential to restore fu
Detailed research on the small animal imaging in vivo market is just released by SkyQuest. Using cutting-edge analytical methods and methodology, this study delivers a thorough industry analysis and a
FREQ Stock: 80.54% Plummet Explanation
05:00pm, Monday, 13'th Feb 2023
The stock price of Frequency Therapeutics Inc (NASDAQ: FREQ) plummeted 80.54% in the most recent trading session. This is why.
LEXINGTON, Mass.--(BUSINESS WIRE)--Frequency Therapeutics, Inc. (Nasdaq: FREQ), a regenerative medicine company focused on developing therapeutics to activate a person's innate potential to restore fu
Frequency Therapeutics Announces Formation of Clinical Advisory Board for Remyelination in Multiple Sclerosis Program
07:30am, Monday, 19'th Dec 2022
LEXINGTON, Mass.--( BUSINESS WIRE )--Frequency Therapeutics, Inc. (Nasdaq: FREQ), a clinical-stage regenerative medicine company focused on developing therapeutics to activate a person's innate potent
LEXINGTON, Mass.--( BUSINESS WIRE )--Frequency Therapeutics, Inc. (Nasdaq: FREQ), a clinical-stage regenerative medicine company focused on developing therapeutics to activate a person's innate potent
NEW YORK , Nov. 29, 2022 /PRNewswire/ -- Purcell & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim
LEXINGTON, Mass.--( BUSINESS WIRE )--Frequency Therapeutics, Inc. (Nasdaq: FREQ), a clinical-stage regenerative medicine company focused on developing therapeutics to activate a person's innate potent
Frequency Therapeutics Provides Business Updates and Third Quarter 2022 Financial Results
04:05pm, Tuesday, 08'th Nov 2022
LEXINGTON, Mass.
Why Tupperware Brands Shares Dipped Around 42%; Here Are 89 Biggest Movers From Yesterday
09:40am, Thursday, 03'rd Nov 2022 Benzinga
Gainers
Starry Group Holdings, Inc. (NYSE: STRY) rose 55.6% to close at $0.28 on Wednesday after reporting Q3 results.
Benefitfocus, Inc. (NASDAQ: BNFT) shares surged 48.2% to settle at $10.36 on We
Benzinga's Top Ratings Upgrades, Downgrades For November 2, 2022
02:06pm, Wednesday, 02'nd Nov 2022 Benzinga
Upgrades
According to Evercore ISI Group, the prior rating for BioCryst Pharmaceuticals Inc (NASDAQ:BCRX) was changed from In-Line to Outperform. In the third quarter, BioCryst Pharmaceuticals showed
Tesla, Twitter And 76 Biggest Movers From Friday
11:30am, Monday, 11'th Jul 2022 Benzinga
Gainers
Seritage Growth Properties (NYSE: SRG) shares surged 80.3% to settle at $10.96 after the company appointed Adam Metz as Chairman. Preliminary proxy materials also indicated the board recomme
Tesla, WD-40 Company And 40 Stocks Moving In Friday's Mid-Day Session
04:20pm, Friday, 08'th Jul 2022 Benzinga
Gainers
Aditxt, Inc. (NASDAQ: ADTX) shares surged 75.7% to $0.2812 after the company's Adimune therapeutic program completed a toxicology study indicating a favorable safety profile of ADI-100.
Serit
Frequency Therapeutics, Inc. (FREQ) Upgraded to Buy: What Does It Mean for the Stock?
04:00pm, Wednesday, 25'th May 2022 Zacks Investment Research
Frequency Therapeutics, Inc. (FREQ) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Frequency Therapeutics, Inc. (FREQ) Upgraded to Buy: What Does It Mean for the Stock?
01:03pm, Wednesday, 25'th May 2022
Frequency Therapeutics, Inc. (FREQ) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
